Table 2.

Detection of P. falciparum and diagnostic performance of the csRDT and the uRDT

	n	TP	FP	TN	FN	Sensitivity (%)		Specificity %		PPV (%)		NPV (%)		DOR		Agreement (κ)
Detection of P. falciparum including non-falciparum species
uRDT	270	31	2	110	127	19.6	(13.9–26.8)	98.2	(93.1–99.7)	93.9	(78.4–98.9)	46.4	(40.0–53.0)	13.4	(3.1–57.4)	0.15	(0.09–0.21)
csRDT Pf-line	270	36	5	107	122	22.8	(16.7–30.3)	95.5	(89.4–98.3)	87.8	(73–95.4)	46.7	(79.8–88.8)	6.3	(2.4–16.7)	0.16	(0.09–0.23)
Detection of P. falciparum excluding non-falciparum species
uRDT	242	31	2	82	127	19.6	(13.9–26.8)	97.6	(90.9–99.6)	93.9	(78.4–98.9)	39.2	(32.6–46.2)	10	(2.3–42.9)	0.13	(0.07–0.13)
csRDT Pf-line	242	36	2	82	122	22.8	(16.7–30.3)	97.6	(90.9–99.6)	94.7	(80.9–99.1)	40.2	(33.5–47.3)	12.1	(2.8–51.6)	0.15	(0.09–0.15)

n number of samples, TP True Positive, FP False positive, TN True Negative, FN False Negative, Sens sensitivity, Spec specificity, lowCI Lower 95% confidence Interval, UpperCI Upper 95% confidence interval, PPV Positive Predictive Value, NPV Negative Predictive Value, DOR Diagnostics odds ratio, k Kappa value